ArticleDrug design, development and therapy2026
Anlotinib Plus Immune Checkpoint Inhibitors versus Chemotherapy in Elderly Patients with Extensive-Stage Small-Cell Lung Cancer: A Real World, Exploratory Study.
Bing-Wei Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.